Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 13.192\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) C=CCn1c(-c2cc(OC)c(OC)c(OC)c2)n[nH]c1=S
b.) CC(=O)C1=C(c2ccccc2)NC(=S)NC1c1ccc(O)c(O)c1
c.) CC(=C1C(=O)c2ccccc2C1=O)N1CCN(c2ccc(F)cc2)CC1
Answer: b. CC(=O)C1=C(c2ccccc2)NC(=S)NC1c1ccc(O)c(O)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)C1=C(c2ccccc2)NC(=S)NC1c1ccc(O)c(O)c1
CC(=O)C1=C(c2ccccc2)NC(=S)NC1c1ccc(O)c(O)c1
1-[4-(3,4-dihydroxyphenyl)-6-phenyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidin-5-yl]ethanone